UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): June 1, 2011
Vitamin Shoppe, Inc.
(Exact name of registrant as specified in its charter)
Delaware | 001-34507 | 11-3664322 | ||
(State or Other Jurisdiction of Incorporation or Organization) |
(Commission File Number) | (IRS Employer Identification No.) |
2101 91st Street
North Bergen, New Jersey 07047
(Addresses of Principal Executive Offices, including Zip Code)
(201) 868-5959
(Registrants Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
ITEM 5.07 | Submission of Matters to a Vote of Security Holders. |
At the Vitamin Shoppe, Inc. (the Company) Annual Meeting of Stockholders held on June 1, 2011 (the Annual Meeting), our stockholders: (a) elected the persons listed below to serve as directors for a term of one year expiring at the 2012 Annual Meeting of Stockholders and until their successors are duly elected and qualified; (b) approved the compensation paid to the Companys named executive officers; (c) voted to recommend that the Board of Directors hold an annual advisory vote on the Companys executive compensation; and (d) ratified the appointment of Deloitte & Touche LLP to serve as the Companys independent registered public accounting firm for the 2011 fiscal year. Set forth below are the voting results for each of these proposals:
a. | All of the director nominees were elected to serve until the Annual Meeting in 2012 and until their respective successors are duly elected and qualified. |
DIRECTOR |
VOTES FOR | VOTES WITHELD | BROKER NON-VOTES | |||||||||
Richard L. Markee |
26,353,168 | 1,335,738 | 362,281 | |||||||||
B. Michael Becker |
27,476,039 | 212,867 | 362,281 | |||||||||
Catherine E. Buggeln |
27,564,008 | 124,898 | 362,281 | |||||||||
John H. Edmondson |
27,560,150 | 128,756 | 362,281 | |||||||||
David H. Edwab |
27,560,000 | 128,906 | 362,281 | |||||||||
Douglas R. Korn |
24,420,086 | 3,268,820 | 362,281 | |||||||||
Richard L. Perkal |
24,419,926 | 3,268,970 | 362,281 | |||||||||
Beth M. Pritchard |
27,449,426 | 239,480 | 362,281 | |||||||||
Katherine Savitt-Lennon |
27,564,458 | 124,448 | 362,281 | |||||||||
Anthony N. Truesdale |
27,064,916 | 623,990 | 362,281 |
b. | An advisory (non-binding) vote approved the executive compensation of our named executive officers. |
FOR |
AGAINST | ABSTAIN | BROKER NON-VOTES | |||||||||
27,539,819 |
143,389 | 3,698 | 362,281 |
c. | An advisory (non-binding) vote was held on the frequency of holding an advisory vote on the executive compensation of our named executive officers. |
ONE YEAR |
TWO YEARS | THREE YEARS | ABSTAIN | BROKER NON-VOTES | ||||||||||||
18,012,975 |
131,442 | 9,543,970 | 519 | 362,281 |
d. | The proposal to ratify the appointment of Deloitte & Touche LLP as the Companys independent registered public accounting firm for the 2011 fiscal year was approved. |
FOR |
AGAINST | ABSTAIN | ||||||
28,047,883 |
438 | 2,866 |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Vitamin Shoppe, Inc. | ||
Date: June 6, 2011 | By: /s/ Brenda Galgano | |
Name: Brenda Galgano | ||
Title: Chief Financial Officer |